Barclays
KEQU icon

Barclays’s Kewaunee Scientific KEQU Stock Holding History

Barclays’s Portfolio KEQU Stock Details KEQU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$206 Sell
6
-674
-99% -$24.4K ﹤0.01% 5034
2026
Q2 		$24.2K Sell
680
-1,457
-68% -$54.1K ﹤0.01% 4550
2026
Q1 		$73.2K Sell
2,137
-320
-13% -$12.4K ﹤0.01% 4159
2025
Q4 		$91.9K Buy
+2,457
New +$100K ﹤0.01% 4604
2025
Q2 		– Sell
-101
Closed -$3.98K – 5410
2025
Q1 		$3.98K Sell
101
-2,152
-96% -$120K ﹤0.01% 4950
2024
Q4 		$139K Sell
2,253
-1,368
-38% -$55.7K ﹤0.01% 4486
2024
Q3 		$121K Buy
+3,621
New +$170K ﹤0.01% 4520
2020
Q1 		– Sell
-1
Closed – – 6310
2019
Q4 		$0 Sell
1
-4
-80% -$63 ﹤0.01% 6581
2019
Q3 		$0 Buy
+5
New +$84 ﹤0.01% 6921

Other funds holding KEQU

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Northeast Investment Management
Northeast Investment Management Boston, Massachusetts $2.79B AUM 21.78% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Barclays's KEQU Position: Q3 2026 in Review

Barclays reduced its Kewaunee Scientific (KEQU) stake by 99% in Q3 2026, selling an estimated $24.4K and leaving 6 shares worth $206. The position accounts for ﹤0.01% of the portfolio, ranked #5034.

Barclays first reported a position in KEQU in Q3 2019 and has held it in 9 quarters since. The position peaked at $139K in Q4 2024. 11 funds tracked by Wall St. Rank hold KEQU as of Q3 2026.

  • Barclays held 6 shares of Kewaunee Scientific worth $206 as of Q3 2026.
  • Barclays sold 674 Kewaunee Scientific shares in Q3 2026, an estimated $24.4K.
  • Kewaunee Scientific made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5034 holding.
  • Barclays first reported a position in Kewaunee Scientific in Q3 2019 and has held it in 9 quarters since.
  • Barclays's Kewaunee Scientific position peaked at $139K in Q4 2024.
  • 11 funds tracked by Wall St. Rank held Kewaunee Scientific as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.